Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
RNA Virus Infections: later-stage trial registry
1 of 3 indexed RNA Virus Infections trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
RNA Virus Infections: 3 US clinical trials tracked, 1 recruiting.
RNA Virus Infections is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ambry Genetics, running 1 of these trials.
Enrollment posture brief
Registry condition rna-virus-infections
OPEN 1 | RECR 33% | LATE 2 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
RNA Virus Infections lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for RNA Virus Infections on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
RNA Virus Infections is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
West Virginia University
NCT04376034
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
Medicago
NCT03301051
COVID-19 and SARS-CoV-2 Detection in Saliva
Ambry Genetics
NCT04517682
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on RNA Virus Infections records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on RNA Virus Infections trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this RNA Virus Infections page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 RNA Virus Infections trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ambry Genetics sponsors the most RNA Virus Infections trials on record, review their full trial history before evaluating a specific study. See Ambry Genetics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This RNA Virus Infections condition card totals 3 registered trials; most-linked intervention Quadrivalent VLP Vaccine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.